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A B S T R A CT  
Despite the existence of two different branches of immunity, 
innate and adaptive, it has been described that both systems are 
characterized by the establishment of memory responses. Indeed, 
it has been shown that cells belonging to the innate immune system 
can express a so-called “trained” memory, although it has different 
features from the adaptive immune memory. Adaptive memory is 
a long-lasting specific memory whereas innate memory involves 
non-specific responses which enhance the immune response 
during a second reinfection. However, many aspects of the trained 
immunity are still unclear. Metabolic and epigenetic 
reprogramming have been pointed as the two processes 
responsible for the establishment of the innate memory. Trained 
immunity seems to be responsible for the heterologous effect of 
many vaccines such as BCG, thus giving insights for the 
development of new therapies. Although its potential beneficial 
role, trained immunity could also have detrimental effects that 
might worsen the progress of certain diseases. The purpose of this 
literature review is to provide an in-depth review on the major 
characteristics of trained immunity, describing the main pathways 
at the basis of the evolution and establishment of memory in innate 
cells. In addition, the present review assesses the modern evidence 
of the impact of trained immunity in health and disease, 
strengthening the hypotheses that this innate memory may be 
considered both in the formulation of new therapeutic strategies 
and in the current therapeutic approaches.  
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1 Introduction 
Humans live in close contact with pathogens, allergenic substances and toxic compounds which could 
potentially disrupt the health of the individual [1]. Despite the enormous number of threats deriving from 
the environment, the homeostasis is continuously balanced through the action of the immune system [2, 
3]. The immune system could be described as a complex interaction and networking among cells to produce 
an effective immune response against causative agents [4]. Host immune response is conventionally divided 
into innate immunity and adaptive immunity, although these two groups strictly interact with each other. 
The innate immunity is a rapid and non-specific response against pathogens, whereas adaptive immunity is 
a slower but antigen-specific response with the capability to establish immunological memory against the 
causative agents [5]. Different cell types and molecular substrates operate during the innate and the adaptive 
response; Figure 1 [6] shows the main components belonging to the two different host immune defense 
mechanisms. The innate immunity acts as a second line of defense, in physical barriers such as skin, gut 
microbiota, gastric acids, mucous, saliva and tears [1, 7]. The cells characterizing the innate immunity are 
granulocytes (basophils, eosinophils and neutrophils), macrophages, dendritic cells (DCs), mast cells and 
natural killer (NK) cells [6]. NK cells and γδ T cells have a cytotoxic action, and these cells could be defined 
as either element of the innate or adaptive immunity [6]. In addition, innate immunity comprises a humoral 
part formed by the complement, a system of more than 30 soluble and surface-expressed proteins, mostly 
zymogens, and bioactive molecules such as defensins or ficolins [1, 5, 8]. The adaptive immune response, 
referred as the third line of defense, 
consists of lymphocytes, classified as B 
cells, CD4+ T cells and CD8+ T cells, and 
a humoral part formed by antibodies, 
which are heterotrimeric glycoproteins 
called immunoglobulins [6, 9]. The 
activation of the adaptive immunity is 
highly dependent on fundamental signals 
released by the previous activation of the 
innate immune response [10, 11]. Hence, 
although the mechanisms of action are 
different, the interaction between the 
adaptive and the innate immunity is 
necessary to achieve an efficient immune 
response [1].  
2 Innate Immunity 
In vertebrates, the innate immune response relies upon myeloid cells that are capable to phagocytose and 
destroy causative agents [12]. The detection of pathogens by the immune cells takes place via the pathogen-
associated molecular patterns (PAMPs), which are components present in a variety of microorganisms but 
absent in the host [13]. PAMPs are recognized by pattern recognition receptors (PRRs) present on the 
surface of immune cells [13, 14]. PRRs are divided into five families, such as Toll-like receptors (TLRs), C-
type lectin receptors (CLRs), Nacht-LRR receptors (NLRs), RIG-I-like receptors (RLRs), and the AIM2-
like receptors (ALRs) [15]. The PRRs could be intracellular cytoplasmic or extracellular transmembrane 
receptors [11, 15], and their bond with the PAMPs triggers many processes including the actuation of the 
adaptive immune response. For instance, the detection of PAMPs by Dectin-1 CLR modulates the uptake 
of the microorganisms via phagocytosis, leading to the production of inflammatory cytokines such as IL-
12 [15, 16], a fundamental cytokine involved in the activation of T Helper 1 (Th1) cells [1]. Indeed, the 
activation of PRRs initiates signaling cascades that promote the transcription of targeted gene encoding for 
cytokines, interferons, pro-inflammatory or microbicide proteins [17, 18]. Macrophages, upon the 
Figure 1: Schematic drawing of the components acting 
during innate and adaptive immunity [6]. 
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interaction between the TLR and the PAMPs, produces IL-8, a protein with chemotactic action that induces 
the recruitment of more immune cells in the site of infection [12]. The secretion of cytokines from the cells 
of the innate immunity (i.e. IL-12, IL-1 or type-1 Interferon) contributes to the activation of the adaptive 
immunity [12]. In addition to pro-inflammatory molecules, the action of the antigen presenting cells (APCs) 
could be considered another fundamental pillar for the synergism of innate and adaptive response. The 
APCs, such as DCs, monocytes and macrophages, express the MHC class II molecules involved in the 
presentation of antigen exogenous peptides to the CD4+ T cells in the lymph nodes [12, 19]. Eventually, 
the activation of T cells enhances the adaptive immune response.  
3 Adaptive Immunity 
The innate immunity is a fast, non-specific primary response able to act against various pathogens. 
However, the high variability of antigenic structures and the capability of microorganisms to mutate has led 
to the implementation of the adaptive immune response [20]. Indeed, the specificity of the adaptive immune 
response against a certain antigen is the result of tailored receptors produced by a recombination of a large 
number of genes during B cells maturation [20-23]. Whereas CD8+ T cells have mainly a cytotoxic action, 
the CD4+ T naïve cells are activated via the presentation of processed antigens on MHC class II molecules 
by the APCs or the B cells [20, 22]. The release of cytokines by the T cells stimulates the clonal expansion 
of antigen-specific B cells and the consequent differentiation in plasma cells, which are responsible for the 
production of specialized antibodies able to opsonize the pathogen in the site of infection [20, 21]. It has 
been widely described the ability of the cells of the adaptive immunity to develop memory. This memory 
leads to a faster and more efficient response in the eradication of the pathogen if it establishes an infection 
in the host for a second time, even after many years [24, 25]. Memory cells also prevent the activation of 
naïve T and B cells during a second infection with the same antigen, thus increasing the promptness of the 
response [7]. For instance, T memory cells interact with APCs more rapidly due to the enhanced expression 
of adhesion molecules on their surface [26]. The concept of memory is the principle upon which vaccines 
has been designed, although thus far the most successful vaccines are those acting against invariant 
pathogens [25, 27]. Despite the memory was usually associate with the adaptive immunity, it has been 
recently shown the capability of the innate immune cells to generate a memory which results in an enhances 
responsiveness to a secondary challenge caused by either the same or a different pathogen [28, 29]. 
4 Evolutionary Perspective of Innate Immune Memory 
From the appearance of the first eukaryotic cell, immune defense mechanisms have been recognized in 
every organism. For instance, amoeba could be considered as an ancient phagocyte [7]. It engulfs food 
recognized by specific receptors which can discriminate the self from the non-self, a principle at the basis 
of the phagocytosis and, furthermore, at the basis of immunity [7, 30]. It has been shown that the 
development of innate immunity occurred before the development of adaptive immunity during the 
evolution of vertebrates [31]. Moreover, adaptive immunity seems to be a unique feature of vertebrates, 
which comprise only the 1% of the whole living organisms, whereas invertebrates lean solely on innate 
immunity [23, 32]. Indeed, there is no evidence about the presence of antibodies in more ancestral 
organisms than in particular species of fish [33]. However, different studies have demonstrated that innate 
immunity in invertebrates may have the capability to establish a memory barely similar to the adaptive 
immune system [32]. B. Lemaitre et al. [34] showed that the production of selected antifungal peptides in 
Drosophila underlined an adaptive and specific immune response against fungal infections. Indeed, specificity 
is the main characteristics at the basis of the development of an adaptive immune response. The specificity 
of the adaptive immune system is related the somatic recombination of a large cluster of genes that results 
in a wide diversity of specific receptors, whereas the antigen receptors belonging to the innate immune cells 
are expressed in the same way as they are codified in the germ line [20, 35]. In the last years, it has been 
discovered an array of diversified receptors in many species of invertebrates such as echinoderms, mollusks 
71 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Trained Immunity at a Glance 
or crustacean, although these receptors do not generate a clonal selection [23]. In their study, J. Kurtz et al. 
[32] demonstrated that copepods produce a more successful response during a second infection of a 
parasite expressing already encountered antigens, thus suggesting that invertebrates might develop immune 
memory features [32]. This assumption has been consolidated by other findings on innate immune memory 
in invertebrates such as mosquitoes, tapeworms and Bombus terrestris [5]. The development of a memory has 
been broadly described also in plants. This memory is called defense priming, and it is established both in 
the harmed tissue and in the unharmed tissue of the plant, generating a stronger defense mechanism upon 
second stimuli [36]. The spread of the protection among tissues in plants has been termed Systemic 
Acquired Resistance (SAR), and it establishes a long-lasting protection against a wide range of pathogens 
[37]. Innate memory has been characterized also in mammals. For instance, mice vaccinated for a certain 
pathogen can be protected against other non-related causative agents [36]. J. C. Sun et al. [38] demonstrated 
the development of a memory in NK cells against a second reinfection with the Cytomegalovirus in a mouse 
model. Another strong evidence of the involvement of an innate immune memory is the heterologous 
effect of BCG vaccine against other pathogens beside the Mycobacterium spp. [37, 39]. For instance, BCG 
vaccine confers protection against secondary infections caused by Candida albicans or Schistosoma mansoni, 
and this protection seems to involve activated macrophages in the tissues [37]. In their study, J. 
Kleinnijenhuis et al. [40] showed that BCG vaccination in healthy volunteers enhanced the production of 
inflammatory cytokines by the NK cells, and the effect on NK cells appeared to be long-lasting.  
The establishment of the innate immune memory relies on similar mechanisms in plants and mammals, i.e. 
epigenetic changes. The epigenetic modifications resulting from the DNA hypo methylation and histone 
methylation (H3K4me3) appear to generate long-lasting memory in the innate immune system which 
becomes more efficient in the context of a second challenge [36]. M. G. Netea et al. [5] suggested a two-
steps evolutionary model which could explain the innate immune memory characterizing all the living 
organisms, but the exclusiveness of the further development of the adaptive immunity in vertebrates. A 
first evolutionary step is dominated by constant epigenetic modifications. These epigenetic modifications 
allowed the growth of a memory responsible for the increased efficacy of the immune response upon a 
second reinfection in all organisms [5]. A second step led to a higher immune response specificity in 
vertebrates through gene recombination and clonal selection [5]. Figure 2 [5] shows the two-steps 
evolutionary hypothesis which could describe the creation of an innate immune memory in plants, 
invertebrates and invertebrates, giving also an insight on the similarities of the immune memory among all 
the living organisms. Nevertheless, the differences or the similarities behind the epigenetic modifications 
triggering a memory in the innate and adaptive immune response are still unclear.  
 
Figure 2: Schematic representation of the two-steps evolutionary hypothesis of the innate and adaptive immune 
memory suggested by M. G. Netea et al. [5]. 
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5 Pillars of Trained Immunity 
Netea et al. [41] named “trained immunity” the memory of the innate immune cells. Analyzing this 
definition, to a certain extent the innate immune cells are trained to remember and better respond to an 
infection. It is possible to underline two main characteristics of trained immunity that differ from the 
classical immunological memory of the adaptive immune cells. Firstly, the cells responsible for the trained 
immunity belong to the innate immune system, and these cells are indeed myeloid cells, NK cells and innate 
lymphoid cells (ILCs) [41]. Moreover, the memory of the trained immunity does not depend on gene 
recombination and antigen-specific reaction but it relies on a non-specific response against pathogens 
induced by epigenetic reprogramming [41]. It has been already discussed the influence of epigenetic changes 
in the development of the cell memory, which could consequently be considered as a pillar of trained 
immunity. In addition, beside the evident importance of metabolism in the functioning of the immune cells, 
it has been described the key role of metabolic pathways in the establishment of a memory both in the 
adaptive and innate immune system [41, 42]. Hence, metabolism could be regarded as the second pillar 
that supports trained immunity.  
5.1 Metabolic Reprogramming 
Regardless of their quiescent or activated status, cells need energy through ATP molecules to carry out their 
functions. The main substrate necessary for cell metabolism is glucose, which is employed as fuel within 
two distinct metabolic pathways, such as the cytoplasmic glycolysis and the mitochondrial oxidative 
phosphorylation (OXPHOS) [43]. Glucose is uptaken by the cell and transformed into pyruvate through 
glycolysis, generating 2 ATPs per molecule of glucose. Pyruvate could then be converted into lactate or 
introduced in the TCA cycle inside the mitochondria, hence starting the OXPHOS metabolic pathway. 
Figure 3 [42] shows the main steps occurring after the uptake of glucose through the Glut-1 transporter on 
the cell membrane.  
 
 
Figure 3: Overview of the metabolic pathways and intermediate metabolites characterizing the cells [42].  
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Via OXPHOS, 30-36 molecules of ATP per molecule of glucose are produced compared to the 2 molecules 
of ATP produced during glycolysis [42, 44], thus figuring the OXPHOS more favorable in terms of amount 
of energy. However, glycolysis appears to provide energy faster to the cells that need to promptly act during 
an early infection. As an example, neutrophils are the first responders to infections, and they utilize 
glycolysis both in the activated and quiescent status, presenting a very low mitochondrial density [42, 45]. 
Another example is depicted by macrophages. It has been observed a significant amount of glycolytic 
enzymes in activated macrophages, underlying a high glycolytic activity, and most of the glucose uptake by 
resting macrophages is converted into lactate [46]. Moreover, M1 macrophages involved in a prompt 
immune response rely on glycolysis, whereas M2 macrophages involved mainly in wound healing rely on 
OXPHOS [43, 46, 47]. Additionally, it has been demonstrated that DCs switch metabolic pathway into 
glycolysis upon activation with TLR agonists [43]. The activation of immune cells is characterized by an 
increased rate of glycolysis, resulting in a metabolic switch from OXPHOS [48]. This switching in 
metabolism is called the “Warburg effect”, and it was firstly described as a main feature of the tumor cells 
which prefer a glycolytic pathway despite the presence of oxygen for a more productive oxidative 
phosphorylation. This metabolic switch hastens the immune cells activation, improving the capability of 
innate immune cell to act as “trained” cells. S. Cheng et al. [49] showed that upon stimulation with β-glucan, 
monocytes shifted the metabolism from OXPHOS to aerobic glycolysis via activation of the AKT-mTOR-
HIF-1α pathway. Therefore, this metabolic change boosted the response of β-glucan-trained monocytes to 
further stimulation [49]. Moreover, the inhibition of mTOR and the glycolytic flux restrained monocyte 
training, both in mice models and humans [49, 50]. Notwithstanding the metabolic shift, the OXPHOS is 
still active, and the TCA cycle intermediates have an impact on epigenetic reprogramming which then lead 
to a trained immunity. High concentration of citrate has been described in inflammatory macrophages, and 
citrate has a fundamental role in the production of pro-inflammatory molecules such as 
prostaglandins, reactive oxygen species, and nitric oxide [51]. The metabolites produced during the 
TCA cycle, such as succinate and fumarate, appeared to be increased in trained macrophages and β-glucan-
trained monocytes [48, 50]. Furthermore, the accumulation of succinate and fumarate seems to stabilize 
the effect of Hif-1α, increasing glycolytic activity [48]. These metabolites deriving from the TCA cycle are 
involved in the long-term reprogramming of trained immune cells [45]. Indeed, it has been largely described 
the correlation of metabolites from the glycolysis and the TCA cycle with the regulation of gene 
transcription, showing that these metabolites function as cofactors for enzymes involved in epigenetic 
changes, i.e. DNA and histone methyltransferases or histone acetyltransferases [50].  
5.2 Epigenetic Reprogramming 
Metabolic reprogramming seems to be strictly related to epigenetic changes. Thus, enzymes acting on 
histones exert metabolites in order to modify histone conformation [45], and the metabolic changes caused 
by an inflammatory stimulus might be responsible for the epigenetic reprogramming that lead to the 
“trained immunity” [52]. Genes expression is regulated via chromatin conformation, which makes DNA 
more or less accessible to transcription factors. Epigenetic chromatin markers have been recently described 
as dynamically influenced by external signals [53]. The chromatin is compartmentalized in units called 
nucleosomes, that are octamer structures formed by 2 copies of 4 core histones such as H2A, H2B, H3, 
and H4 [53, 54]. When nucleosomes are strictly bundled, genes are poorly accessible and the transcription 
is hindered. In contrast, when nucleosomes are unfolded, genes are easily accessible and the transcription 
is activated. Histone modifications such as acetylation and methylation enhance or inhibit gene expression 
through the activity of different enzymes. As an example, methylation at H3K27 and H3K9 with repressive 
marks and co-repressor enzymes prevents the activation of interferon-response genes in mouse bone-
marrow-derived macrophages during the resting state of the cells in the absence of stimuli [55]. However, 
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histone modifications are reversible, and the inhibition of gene transcription can be counteracted and 
enhanced. Indeed, gene expression is activated upon external stimuli via the accumulation of epigenetic 
marks in promoters, which interacts with polymerase II to initiate gene transcription, and enhancers, which 
are recognized by transcription factors [53, 55]. Methylation at H3K4 and H3K36 induced upon stimulation 
with bacterial lipopolysaccharide (LPS) makes chromatin more accessible and permissive for the 
transcription of many genes [53, 55].  
It has been described that enzymes involved in histones methylation and acetylation cooperate with 
intermediate metabolites deriving from the TCA cycle during glycolysis and OXPHOS. For instance, 
Acetyl-CoA is necessary for histone acetyltransferases, whereas α-ketoglutarate and flavin adenine 
dinucleotide (FAD) act as cofactors for DNA and histone demethylases [45, 54]. Encountering the 
pathogen promotes the modification of histones in monocytes and macrophages, altering the genes 
expression after a second stimulation [45]. Hence, histone modifications are considered the second 
fundamental building block of trained immunity together with the metabolic changes. In their study, J. 
Quintin et al. [56] underlined that the trimethylation of H3K4 (H3K4me3) is enhanced and stabilized in β-
glucan-trained monocytes. The enrichment of H3K4me3 at promoter regions characterizes trained 
immunity, increasing the transcription of genes encoding for proinflammatory cytokines, and it has been 
described as a feature of the heterologous effect of the BCG vaccine [57]. Moreover, J. Quintin et al. [56] 
demonstrated that H3K4me3 and acetylation of H3K27 (H3K27ac) observed in monocytes after the first 
stimulus with β-glucan were correlated with a metabolic switch into glycolysis. Histone modifications such 
as H3K4me3 and H3K27ac have been pointed as a consequence of metabolic changes within the cells, 
suggesting fumarate as one of the major metabolites from the TCA cycle responsible for epigenetic 
reprogramming [50]. To consolidate the interplay between metabolic and epigenetic reprogramming, it has 
been described that by blocking glycolytic enzymes in trained monocytes, the histone marks H3K4me3 and 
H3K9me3 characterizing trained immunity are inhibited [28]. The stronger innate immune response upon 
second stimulation seems to be associated with the presence of latent or de novo enhancers [41, 57]. The 
scheme represented in Figure 4 [41] describes the concept of de novo enhancers. After the first stimulation 
H3K4me3, the chromatin mark is only partially removed, with the establishment of a latent enhancer that 
allows a faster gene transcription and therefore a faster immune response during a reinfection. Indeed, the 
mono methylation of H3K4 (H3K4me1) kept slightly opened the chromatin, thus more accessible to 
transcription factors. Many studies have been done to characterized the mechanisms generating trained 
immunity. However, more insights are needed to deepen the knowledge on these mechanisms and further 
develop new treatments in diseases correlated with the immune system.  
 
Figure 4:  Epigenetic changes of trained immunity characterized by the establishment of  
latent or de novo enhancers [41]. 
75 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Trained Immunity at a Glance 
5.3 Potential of Trained Immunity to Enhance Therapies 
The establishment of trained memory enhances the innate immune response, thus resulting in a faster 
elimination of the infection. Additionally, this memory is characterized by cross-protection during a 
secondary challenge caused by either the same or a different pathogen [58]. The role of trained immunity 
in the enhancement of protection against infection could be identified in the non-specific protection 
induced by different vaccines. One of the most studied vaccines presenting non-specific protection is the 
Bacillus Calmette-Guérin (BCG) vaccine. The BCG vaccine is a live attenuated vaccine consisting of 
Mycobacterium bovis, and it is largely used against tuberculosis infection [59]. Different studies showed a 
decreased in neonatal mortality in infants vaccinated with BCG compared to non-vaccinated infants, data 
that could not be associated only as a result of protection against tuberculosis [49]. Therefore, it has been 
proposed an involvement of trained immunity which could be responsible for the cross-protection of 
vaccines against infections. In their study, J. Kleinnijenhuis et al. [60] reported a higher released of cytokines 
in response to unrelated pathogens in healthy volunteers after BCG vaccination. Moreover, they showed 
that Severe Combined Immunodeficiency (SCID) mice were totally protected against disseminated 
candidiasis after BCG vaccinations, with a 100% survival compared to 30% survival of non-vaccinated 
SCID mice [60]. They demonstrated that the mechanism through which BCG vaccine increases the innate 
immune response is a NOD2-mediated epigenetic change at the level of histone methylation (H3K4me3) 
[60]. M. Parra et al. [61] found that BCG vaccines induce expression of 4 host genes encoding for 
fundamental antimicrobial peptides, such as lactoferrin and cathelicidin-type peptide. These peptides 
reduce parasitemia in mice infected with the malaria parasite [61]. Another study supported the activity of 
BCG vaccine against malaria parasites and tegumentary leishmaniasis [62]. Furthermore, BCG vaccines 
seem to improve NK cells activity in humans [63]. In addition, peripheral blood mononuclear cells 
(PBMCs) revealed an upregulation in glycolysis after BCG vaccination [64]. BCG vaccine is also employed 
in the treatment of bladder cancer. In the guidelines of the European Association of Urology (EAU) BCG 
is recommended for intermediate-risk patients failed for intravesical chemotherapy and as the first 
treatment choice in high-risk patients [65]. 
The mechanism through which BCG vaccine stimulates trained immunity remaines unclear. However, a 
potential role of autophagy has been hypothesized. The autophagy of BCG by monocytes and macrophages 
might lead to a released of MDP that activates NOD2, which then induces epigenetic reprogramming of 
the cells [63]. It has been also shown that trained immunity impact hematopoietic progenitors and 
myelopoiesis, suggesting that trained immunity has an effect both on the mature myeloid cells and precursor 
cells [66]. Indeed, I. Mitroulis et al. [66] proved that β-glucan-induced trained immunity promotes 
hematopoietic stem cells expansion and myelopoiesis, thus conferring a protective response to a second 
stimulus.  
Besides BCG vaccine, other vaccines have been reported to confer a non-specific protection. Vaccinia has 
been largely used to vaccinate against smallpox, an infectious disease declared eradicated by the World 
Health Organization (WHO) in 1980. Non-specific protection of vaccinia upon melanoma and non-
Hodgkin lymphoma has also been described [63]. Studies conducted in Africa underlined a lower mortality 
risk in adults vaccinated against smallpox [58]. G. O. Gillard et al. [67] demonstrated that NK liver cells 
primed with vaccinia virus conferred protection in mice lacking of adaptive immune cells. Another example 
is influenza vaccine, which appears to induce secondary protection to respiratory infections in children [58]. 
Moreover, influenza vaccine might be promising in the reduction of post-operative metastatic diseases via 
the enhancement of NK cells [68].  
Trained immunity has recently been studied for the development of Trained Immunity-based Vaccines 
(TIbVs). Figure 5 [58] represents how TIbVs could result in a broader protection against infections through 
the stimulation of both trained and adaptive immunity. TIbVs are composed by TI inducers and Antigens 
(Ags). TI inducers could be defined as a mixture of PAMPs recognized by a variety of PPRs. Once activated, 
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PRRs trigger epigenetic and metabolic reprogramming, upregulation of glycolysis and production of pro-
inflammatory cytokines, leading to trained immunity, which confer a non-specific protection against 
pathogens. Ags are specific antigens related to the pathogen which trigger the activation of adaptive 
immunity, hence resulting in a specific immune response.  
 
Figure 5: Overview of Trained Immunity-based Vaccines composition and functioning [58]. 
A variety of PRRs seems to be promote trained immunity inducing a change in cellular metabolism by 
acting on CLRs or NLRs [58]. Therefore, new combinations of PRRs as TIbVs formulas could lead 
different trained immunity effects and a more efficient therapeutic result. Moreover, the primed functional 
state of trained cells appears to last long, and it could provide protection to causative agents that comes 
into contact with the host during this period of time [58]. As a matter of the fact that enhanced innate 
immune response to reinfection has been described in organisms lacking adaptive immunity and in SCID 
mice [60, 69], one could speculate that TIbVs could be useful for the treatment of patients with adaptive 
immunodeficiency. Moreover, these vaccines could be useful against infections that do not have a 
conventional prophylaxis yet, or they could be used to prevent illnesses derived from virus and bacteria co-
infections [58]. However, there is still uncertainty about the lasting of the innate immune memory compared 
to the lifelong memory and consequent immunization provided by the adaptive immune cells. Indeed, it is 
claimed that the effect of trained immunity may last for maximum few months rather than many years [70].  
5.4 Detrimental Activity of Trained Immunity 
The beneficial role of trained immunity in the development of new therapeutic strategies is a new field of 
study that could improve treatments against infections and diseases. However, the enhanced response of 
the immune cells has been also described as potentially detrimental. The first scenario that underlines 
detrimental effects mediated by trained innate immunity is represented by organ rejection after 
transplantation. The innate immune system is able to discriminate self and non-self molecules. The 
recognition of non-self molecules initiates a fast inflammatory response and the differentiation of APCs, 
which present the non-self antigen to the adaptive T cells [71]. Moreover, studies in mammals showed the 
so called alloimmunity, such as the triggering of the immune response to cells or tissues belonging to 
members the same species, and it might occur during organs and bone marrow transplantation or even 
during pregnancy [71]. Hence, to prevent organ rejection, the main suppressive immune therapies target 
the T cells activation by inhibiting essential signals such as antigen presentation, co-stimulation or cytokine 
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productions [72]. However, the long-term survival rate is still unsatisfactory [72]. M. H. Oberbanscheidt et 
al. [71] demonstrated that allogeneic grafts trigger proliferation and differentiation of monocytes into DCs 
in lymphoid-cell deficient mice, thus suggesting a fundamental role of innate immune system in organ 
transplantation. Another finding supported the monocytes alloimmune response which is independent 
from T, B and NK cells [73]. In addition, the monocytes manifests memory and they need prior priming 
with allogeneic non-self [73]. According to additional data, infiltration of monocytes and macrophages 
characterize the rejection in T-cell depleted human renal allograft recipients, reaffirming the involvement 
of the monocytes in the initiation of the alloimmune response [72]. A role of macrophages in alloimmunity 
has been described. The epigenetic reprogramming of macrophages and the consequent establishment of 
a nonpermanent innate memory appears to be triggered not only by PAMPs but also by damage‐associated 
molecular patterns (DAMPs), usually released during tissue damage and after organ and tissue 
transplantation [71, 72].  
Atherosclerosis is a chronic inflammatory disease in the artery wall, and it consists in a sub-endothelial 
accumulation of plasma lipoproteins which results in infiltration of macrophages and Th1 cells to form a 
plaque [74]. Macrophages constantly phagocyte the lipoprotein, thus becoming the so-called foam cells. 
Risk factors are identified in diabetes, smoke, hypertensions, chronic kidney disease (CKD) and a role of 
the immune system in the progression of the disease is emerged [74, 75]. New evidences linked trained 
immunity as a potential contributor to the chronic inflammation status of the blood vessels wall. S. 
Bekkering et al. [76] showed that exposure of modified LDL to monocytes-derived macrophages induced 
a long-lasting pro-inflammatory phenotype due to epigenetic reprogramming. Trained immunity as a 
potential cause of the chronic inflammatory status could be a novel pharmacological target in the treatment 
of the disease [76]. The same epigenetic reprogramming in monocytes-derived macrophages has been 
described upon stimulation with Lp(a) [77]. Hence, modified LDL and Lp(a) induce the epigenetic 
reprogramming and training of macrophages which then intensify their inflammatory response, resulting in 
a worsen inflammation [78]. 
Sepsis is the consequence of an exaggerated release of inflammatory cytokines in response to an infection, 
and it may lead to a septic shock [79]. In physiological situations, the infection induces a pro-inflammatory 
response to remove the causative agent and afterwards an anti-inflammatory response to avoid hyper 
inflammation and consequent tissue damage. The pro and anti-inflammatory response are balanced. 
However, if the pro-inflammatory response is excessive, the balance is disrupted and the responsiveness of 
the anti-inflammatory pathways becomes abnormal [79]. Therefore, after 24-48 hours of hyper 
inflammation, there is an excessive activation of anti-inflammatory responses which leads to an 
immunosuppression known as immunoparalysis [45, 79]. A major threat for patients in the 
immunoparalysis state is represented by secondary infections that may lead to death. There are divergent 
findings on the suppressive action of sepsis on hematopoiesis [80, 81]. However, K. Bomans et al. [80] 
underlined an enhanced hematopoiesis in post-septic mice. Moreover, they demonstrated that monocytes 
isolated from the bone marrow showed a higher responsivity upon second stimulation, thus indicating a 
trained immune state after sepsis at the bone marrow level [80]. Nevertheless, immunoparalysis after sepsis 
is related to innate immune tolerance, and this phenomenon has been largely studied via the endotoxin 
tolerance with lipopolysaccharides (LPS) [82]. In this latter case, one could speculate that inducing a trained 
immune state might avoid an exaggerated anti-inflammatory response.  
Trained immunity increases the responsiveness of the innate immune system to secondary stimuli [45], 
resulting in a positive and faster eradication of infections or in aggravated conditions. The detrimental roles 
of trained immunity in different medical conditions are becoming more and more evident. Further studies 
are required to deepen the knowledge of the innate immune memory. Consequently, new therapeutic 
approaches based on metabolic, epigenetic and immunological pathways targeting trained immunity could 
be developed to increase and promote the health of patients.  
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6 Conclusions 
The immune system comprises innate and adaptive immunity. The innate and the adaptive immunity have 
always been described as two different systems with specific characteristics and functions. However, in the 
past decades the immune system has been redrawn as the result of sophisticated interactions among innate 
and adaptive cells, and these cells may share a common feature, such as memory. Memory has always been 
related to adaptive immunity, leading to a specific response to a reinfection caused by the same pathogen. 
This principle drove to the development of vaccines, which improved the immunization against certain 
pathogens and, in some cases, allowed the eradication of them. In recent years, the discovery of innate 
immune memory opened new perspectives in research and medicine. Indeed, innate immune cells undergo 
through metabolic and epigenetic reprogramming that enhance a non-specific response to a second 
infection caused by either the same or a different pathogen. Trained immunity seems to be responsible for 
the heterologous, non-specific effect of some vaccines, such as BCG vaccine, influenza vaccine or vaccinia. 
As an example, BCG vaccine is currently used as a therapy for bladder cancer, it has been described to 
enhance protection against protozoan infections such as malaria or tegumentary leishmaniasis and it reduces 
neonatal mortality. Therefore, these discoveries led to the formulation of new potential Trained Immunity-
derived Vaccines, enhancing both the innate and adaptive memory for a broader immunity. TIbVs could 
be beneficial in the therapy of the adaptive immunodeficiency and could guarantee a protection to co-
infections or against pathogens that has no conventional vaccines yet. However, many aspects of trained 
immunity need to be deepened. The long-lasting protective effect of trained immunity is still on debate, 
and it seems to be no longer than few months compared to the lifelong immunization of the adaptive 
immune cells. Moreover, many detrimental side effects of trained immunity have been described. 
Macrophages undergo to epigenetic reprogramming in atherosclerosis, worsen the inflammation status. 
Trained monocytes and macrophages seem to be responsible for the alloimmune response resulting in the 
rejection of allografts in organ and tissue transplantation. The role of trained immunity during sepsis could 
be either beneficial or detrimental. Indeed, it has been shown an increased hematopoietic rate and a trained 
immune status in monocytes isolated from the bone marrow after sepsis. However, the implement of 
trained immunity might avoid the immunoparalysis, thus reducing the risk of mortality after sepsis due to 
secondary infections. Further studies are needed to achieve more insights on the role of trained immunity 
in infections and diseases. Manipulation of trained immunity through immunologic, metabolic and 
epigenetic pathways could improve the efficacy and duration of therapies, and it could reduce the mortality 
rates and worsening of certain immune-related diseases.  
7 Competing Interests 
The authors declare that they have no known competing financial interests or personal relationships that 
could have appeared to influence the work reported in this paper. 
8 How to Cite this Article: 
Will be updated in the final version. 
References 
[1] Chaplin, D.D., Overview of the immune response. The Journal of allergy and clinical immunology, 2010. 125(2 Suppl 2): p. S3-S23. 
https://doi.org/10.1016/j.jaci.2009.12.980. 
[2] Chaplin, D.D., 1. Overview of the human immune response. Journal of Allergy and Clinical Immunology, 2006. 117(2, Supplement 
2): p. S430-S435. https://doi.org/10.1016/j.jaci.2005.09.034 
[3] Accolla, R., Host Defense Mechanisms against Pathogens. 2006. 7 (supplement 2): p.s5-s7. https://doi.org/10.1089/sur.2006.7.s2-5 
[4] Furman, D. and M.M. Davis, New approaches to understanding the immune response to vaccination and infection. Vaccine, 2015. 
33(40): p. 5271-5281.  https://doi.org/10.1016/j.vaccine.2015.06.117 
[5] Netea, M.G., et al., Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host’s Response to Pathogens. Cell 
Host & Microbe, 2019. 25(1): p. 13-26.  https://doi.org/10.1016/j.chom.2018.12.006 
[6] Dranoff, G., Cytokines in cancer pathogenesis and cancer therapy. Nature Reviews Cancer, 2004. 4(1): p. 11-22. 
https://doi.org/10.1038/nrc1252 
79 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Trained Immunity at a Glance 
[7] Janeway CA Jr, T.P., Walport M, et al., The front line of host defense. Immunobiology: The Immune System in Health and Disease, 
2001. 5th edition. https://www.ncbi.nlm.nih.gov/books/NBK10757/ 
[8] Mathern, D.R. and P.S. Heeger, Molecules Great and Small: The Complement System. Clinical journal of the American Society of 
Nephrology : CJASN, 2015. 10(9): p. 1636-1650. https://doi.org/10.2215/CJN.06230614 
[9] Schroeder, H.W., Jr. and L. Cavacini, Structure and function of immunoglobulins. The Journal of allergy and clinical immunology, 
2010. 125(2 Suppl 2): p. S41-S52. https://doi.org/10.1016/j.jaci.2009.09.046. 
[10] Schenten, D. and R. Medzhitov, Chapter 3 - The Control of Adaptive Immune Responses by the Innate Immune System, in Advances 
in Immunology, F.W. Alt, Editor. 2011, Academic Press. p. 87-124. https://doi.org/10.1016/B978-0-12-387664-5.00003-0. 
[11] Noah W. Palm, R.M., Pattern recognition receptors and control of adaptive immunity. Immunological Reviews, 19 December 2008. 
https://doi.org/10.1111/j.1600-065X.2008.00731.x 
[12] Beutler, B., Innate immunity: an overview. Molecular Immunology, 2004. 40(12): p. 845-859. 
https://doi.org/10.1016/j.molimm.2003.10.005 
[13] Mushegian, A. and R. Medzhitov, Evolutionary perspective on innate immune recognition. The Journal of cell biology, 2001. 155(5): 
p. 705-710. https://doi.org/10.1083/jcb.200107040 
[14] Tang, D., et al., PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunological reviews, 2012. 249(1): p. 158-
175. https://doi.org/10.1111/j.1600-065X.2012.01146.x. 
[15] Brubaker, S.W., et al., Innate immune pattern recognition: a cell biological perspective. Annual review of immunology, 2015. 33: p. 
257-290.  https://doi.org/10.1146/annurev-immunol-032414-112240. 
[16] Romagnolo, A.G., et al., Role of Dectin-1 receptor on cytokine production by human monocytes challenged with Paracoccidioides 
brasiliensis. 2018. 61(4): p. 222-230. https://doi.org/10.1111/myc.12725 
[17] Lamkanfi, M. and Vishva M. Dixit, Mechanisms and Functions of Inflammasomes. Cell, 2014. 157(5): p. 1013-1022. 
https://doi.org/10.1016/j.cell.2014.04.007. 
[18] Ulevitch, R.J., Regulation of Receptor-Dependent Activation of the Innate Immune Response. The Journal of Infectious Diseases, 
2003. 187(Supplement_2): p. S351-5. https://doi.org/10.1086/374605 
[19] Goldman AS, P.B., Immunology Overview. Medical Microbiology, 1996. 4th edition. 
https://www.ncbi.nlm.nih.gov/books/NBK7795/ 
[20] Bonilla, F.A. and H.C. Oettgen, Adaptive immunity. Journal of Allergy and Clinical Immunology, 2010. 125(2, Supplement 2): p. 
S33-S40. https://doi.org/10.1016/j.jaci.2009.09.017 
[21] Nutt, S.L., et al., The generation of antibody-secreting plasma cells. Nature Reviews Immunology, 2015. 15(3): p. 160-171. 
https://doi.org/10.1038/nri3795. 
[22] Evavold, C.L. and J.C. Kagan, How Inflammasomes Inform Adaptive Immunity. Journal of Molecular Biology, 2018. 430(2): p. 217-
237.  https://doi.org/10.1016/j.jmb.2017.09.019.  
[23] Gourbal, B., et al., Innate immune memory: An evolutionary perspective. 2018. 283(1): p. 21-40. https://doi.org/10.1111/imr.12647. 
[24] Ratajczak, W., et al., Immunological memory cells. Central-European journal of immunology, 2018. 43(2): p. 194-203. 
https://doi.org/10.5114/ceji.2018.77390 
[25] Sallusto, F., et al., From Vaccines to Memory and Back. Immunity, 2010. 33(4): p. 451-463. 
https://doi.org/10.1016/j.immuni.2010.10.008. 
[26] Ahmed, R. and D. Gray, Immunological Memory and Protective Immunity: Understanding Their Relation. 1996. 272(5258): p. 54-
60. https://doi.org/10.1126/science.272.5258.54 
[27] Campos, M. and D.L. Godson, The effectiveness and limitations of immune memory: understanding protective immune responses. 
International Journal for Parasitology, 2003. 33(5): p. 655-661. https://doi.org/10.1016/s0020-7519(03)00066-3 
[28] Mulder, W.J.M., et al., Therapeutic targeting of trained immunity. Nature Reviews Drug Discovery, 2019. 18(7): p. 553-566. 
https://doi.org/10.1038/s41573-019-0025-4. 
[29] Netea, M.G. and J.W.M. van der Meer, Trained Immunity: An Ancient Way of Remembering. Cell Host & Microbe, 2017. 21(3): p. 
297-300. doi: 10.1016/j.chom.2017.02.003. 
[30] Buchmann, K., Evolution of Innate Immunity: Clues from Invertebrates via Fish to Mammals. Frontiers in immunology, 2014. 5: p. 
459-459. https://doi.org/10.3389/fimmu.2014.00459. 
[31] Medzhitov, R. and C.A. Janeway, An ancient system of host defense. Current Opinion in Immunology, 1998. 10(1): p. 12-15. 
https://doi.org/10.1016/s0952-7915(98)80024-1 
[32] Kurtz, J., Specific memory within innate immune systems. Trends in Immunology, 2005. 26(4): p. 186-192. 
https://doi.org/10.1016/j.it.2005.02.001 
[33] Boman, H.G., I. Nilsson, and B. Rasmuson, Inducible Antibacterial Defence System in Drosophila. Nature, 1972. 237(5352): p. 232-
235. https://doi.org/10.1038/237232a0 
[34] Lemaitre, B., J.M. Reichhart, and J.A. Hoffmann, Drosophila host defense: differential induction of antimicrobial peptide genes after 
infection by various classes of microorganisms. Proceedings of the National Academy of Sciences of the United States of America, 
1997. 94(26): p. 14614-14619. https://doi.org/10.1073/pnas.94.26.14614 
[35] Milutinović, B. and J. Kurtz, Immune memory in invertebrates. Seminars in Immunology, 2016. 28(4): p. 328-342. 
https://doi.org/10.1016/j.smim.2016.05.004. 
[36] Reimer-Michalski, E.-M. and U. Conrath, Innate immune memory in plants. Seminars in Immunology, 2016. 28(4): p. 319-327. 
https://doi.org/10.1016/j.smim.2016.05.006 
[37] Netea, Mihai G., J. Quintin, and Jos W.M. van der Meer, Trained Immunity: A Memory for Innate Host Defense. Cell Host & Microbe, 
2011. 9(5): p. 355-361. https://doi.org/10.1016/j.chom.2011.04.006. 
[38] Sun, J.C., J.N. Beilke, and L.L. Lanier, Adaptive immune features of natural killer cells. Nature, 2009. 457(7229): p. 557-561. 
https://doi.org/10.1038/nature07665. 
[39] Netea, M.G. and R. van Crevel, BCG-induced protection: Effects on innate immune memory. Seminars in Immunology, 2014. 26(6): 
p. 512-517. https://doi.org/10.1016/j.smim.2014.09.006. 
80 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Incalcaterra et al., Adv. J.  Grad.  Res.; Vol. 8, Issue 1, pp: 68-81, July 2020 
[40] Kleinnijenhuis, J., et al., BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. Clinical 
Immunology, 2014. 155(2): p. 213-219.  https://doi.org/10.1016/j.clim.2014.10.005 
[41] Netea, M.G., et al., Trained immunity: A program of innate immune memory in health and disease. Science, 2016. 352(6284): p. 
aaf1098.  https://doi.org/10.1126/science.aaf1098  
[42] Ganeshan, K. and A. Chawla, Metabolic Regulation of Immune Responses. 2014. 32(1): p. 609-634. https://doi.org/10.1146/annurev-
immunol-032713-120236. 
[43] Pearce, E.L. and E.J. Pearce, Metabolic pathways in immune cell activation and quiescence. Immunity, 2013. 38(4): p. 633-643. 
https://doi.org/10.1016/j.immuni.2013.04.005. 
[44] du Plessis, S.S., et al., Oxidative phosphorylation versus glycolysis: what fuel do spermatozoa use? Asian journal of andrology, 2015. 
17(2): p. 230-235. https://doi.org/10.4103/1008-682X.135123 
[45] Dominguez-Andres, J. and M.G. Netea, Long-term reprogramming of the innate immune system. 2019. 105(2): p. 329-338. 
https://doi.org/10.1002/JLB.MR0318-104R. 
[46] Kelly, B. and L.A.J. O'Neill, Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell research, 2015. 
25(7): p. 771-784. https://doi.org/10.1038/cr.2015.68 
[47] O'Neill, L.A.J. and E.J. Pearce, Immunometabolism governs dendritic cell and macrophage function. The Journal of experimental 
medicine, 2016. 213(1): p. 15-23. https://doi.org/10.1084/jem.20151570.  
[48] Arts, R.J.W., L.A.B. Joosten, and M.G. Netea, Immunometabolic circuits in trained immunity. Seminars in Immunology, 2016. 28(5): 
p. 425-430. https://doi.org/10.1016/j.smim.2016.09.002 
[49] Cheng, S.-C., et al., mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity. 2014. 345(6204): p. 
1250684. https://doi.org/10.1126/science.1250684. 
[50] Arts, R.J.W., et al., Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained 
Immunity. Cell Metabolism, 2016. 24(6): p. 807-819. https://doi.org/10.1016/j.cmet.2016.10.008. 
[51] Domínguez-Andrés, J., L.A.B. Joosten, and M.G. Netea, Induction of innate immune memory: the role of cellular metabolism. Current 
Opinion in Immunology, 2019. 56: p. 10-16. doi: 10.1016/j.coi.2018.09.001. 
[52] Yahya Sohrabi, R.G., Hannes M. Findeisen, Altered Cellular Metabolism Drives Trained Immunity. Trends in Endocrinology and 
Metabolism, 2018. 29 (9): p. 602-605.  https://doi.org/10.1016/j.tem.2018.03.012. 
[53] Chen, S., et al., Epigenetic regulation of macrophages: from homeostasis maintenance to host defense. Cellular & Molecular 
Immunology, 2020. 17(1): p. 36-49. https://doi.org/10.1038/s41423-019-0315-0 
[54] Samuel T. Keating, A.E.-O., Epigenetic and Metabolism. Circulation Research, 2015. 116: p. 715-736. 
https://doi.org/10.1161/CIRCRESAHA.116.303936 
[55] Rodriguez, R.M., B. Suarez-Alvarez, and C. Lopez-Larrea, Therapeutic Epigenetic Reprogramming of Trained Immunity in Myeloid 
Cells. Trends in Immunology, 2019. 40(1): p. 66-80. https://doi.org/10.1016/j.it.2018.11.006. 
[56] Quintin, J., et al., Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes. 
Cell Host & Microbe, 2012. 12(2): p. 223-232. https://doi.org/10.1016/j.chom.2012.06.006. 
[57] van der Heijden, C.D.C.C., et al., Epigenetics and Trained Immunity. Antioxidants & redox signaling, 2018. 29(11): p. 1023-1040. 
https://doi.org/10.1089/ars.2017.7310. 
[58] Sánchez-Ramón, S., et al., Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-
infectious Formulations. 2018. 9(2936). https://doi.org/10.3389/fimmu.2018.02936 
[59] Oliveira, T.L., et al., Recombinant BCG strains expressing chimeric proteins derived from Leptospira protect hamsters against 
leptospirosis. Vaccine, 2019. 37(6): p. 776-782. https://doi.org/10.1016/j.vaccine.2018.12.050. 
[60] Kleinnijenhuis, J., et al., Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic 
reprogramming of monocytes. 2012. 109(43): p. 17537-17542. https://doi.org/10.1073/pnas.1202870109 
[61] Parra, M., et al., Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination. PLOS ONE, 
2013. 8(7): p. e66115. https://doi.org/10.1371/journal.pone.0066115 
[62] dos Santos, J.C., et al., Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria. Clinical 
Microbiology and Infection, 2019. 25(12): p. 1479-1483. https://doi.org/10.1016/j.cmi.2019.06.002 
[63] Blok, B.A., et al., Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. 2015. 98(3): 
p. 347-356.  https://doi.org/10.1189/jlb.5RI0315-096R 
[64] de Bree, L.C.J., et al., Non-specific effects of vaccines: Current evidence and potential implications. Seminars in Immunology, 2018. 
39: p. 35-43. https://doi.org/10.1016/j.smim.2018.06.002 
[65] Babjuk, M., et al., EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder. European Urology, 2008. 54(2): 
p. 303-314. https://doi.org/10.1016/j.eururo.2008.04.051 
[66] Mitroulis, I., et al., Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. Cell, 2018. 172: p. 147-
161.e12. https://doi.org/10.1016/j.cell.2017.11.034 
[67] Gillard, G.O., et al., Thy1+ Nk Cells from Vaccinia Virus-Primed Mice Confer Protection against Vaccinia Virus Challenge in the 
Absence of Adaptive Lymphocytes. PLOS Pathogens, 2011. 7(8): p. e1002141. https://doi.org/10.1371/annotation/b29086ef-e08d-
444c-8113-18a6dd429a7c 
[68] Tai, L.-H., et al., Perioperative Influenza Vaccination Reduces Postoperative Metastatic Disease by Reversing Surgery-Induced 
Dysfunction in Natural Killer Cells. 2013. 19(18): p. 5104-5115. https://doi.org/10.1158/1078-0432.CCR-13-0246 
[69] Gyssens, I.C. and M.G. Netea, Heterologous effects of vaccination and trained immunity. Clinical Microbiology and Infection, 2019. 
25(12): p. 1457-1458. https://doi.org/10.1016/j.cmi.2019.05.024 
[70] Gardiner, C.M. and K.H.G. Mills, The cells that mediate innate immune memory and their functional significance in inflammatory 
and infectious diseases. Seminars in Immunology, 2016. 28(4): p. 343-350. https://doi.org/10.1016/j.smim.2016.03.001 
[71] Oberbarnscheidt, M.H., et al., Non-self recognition by monocytes initiates allograft rejection. The Journal of clinical investigation, 
2014. 124(8): p. 3579-3589. https://doi.org/10.1172/JCI74370 
[72] Ochando, J., et al., “Trained immunity in organ transplantation” Am J Transplant. 20: 10– 18, 2020.  https://doi.org/10.1111/ajt.15620 
81 
 
 ISSN: 2456-7108 
Available online at Journals.aijr.in 
Trained Immunity at a Glance 
[73] Zecher, D., et al., An Innate Response to Allogeneic Nonself Mediated by Monocytes. 2009. 183(12): p. 7810-7816. 
https://doi.org/10.4049/jimmunol.0902194  
[74] Gisterå, A. and G.K. Hansson, The immunology of atherosclerosis. Nature Reviews Nephrology, 2017. 13(6): p. 368-380. 
https://doi.org/10.1038/nrneph.2017.51 
[75] Libby, P., et al., Atherosclerosis. Nature Reviews Disease Primers, 2019. 5(1): p. 56. 
https://doi.org/10.1161/CIRCRESAHA.116.308334 
[76] Siroon Bekkering , J.Q., Leo A.B. Joosten , Jos W.M. van der Meer , Mihai G. Netea ,  Niels P. Riksen, Oxidized Low-Density 
Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of 
Monocytes. Arteriosclerosis, Thrombosis, and Vascular Biology, 2014. 34: p. 1731–1738. 
https://doi.org/10.1161/ATVBAHA.114.303887 
[77] van der Valk, F.M., et al., Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte 
Response in Humans. Circulation, 2016. 134(8): p. 611-624. https://doi.org/10.1161/CIRCULATIONAHA.116.020838 
[78] van Tuijl, J., et al., Immunometabolism orchestrates training of innate immunity in atherosclerosis. Cardiovascular Research, 2019. 
115(9): p. 1416-1424. https://doi.org/10.1093/cvr/cvz107 
[79] Wentowski, C., N. Mewada, and N.D. Nielsen, Sepsis in 2018: a review. Anaesthesia & Intensive Care Medicine, 2019. 20(1): p. 6-
13. https://doi.org/10.1016/j.mpaic.2018.11.009 
[80] Bomans, K., et al., Sepsis Induces a Long-Lasting State of Trained Immunity in Bone Marrow Monocytes. Frontiers in immunology, 
2018. 9: p. 2685-2685. https://doi.org/10.3389/fimmu.2018.02685 
[81] Zhang, H., et al., Sepsis Induces Hematopoietic Stem Cell Exhaustion and Myelosuppression through Distinct Contributions of TRIF 
and MYD88. Stem cell reports, 2016. 6(6): p. 940-956. https://doi.org/10.1016/j.stemcr.2016.05.002 
[82] van der Meer, J.W.M., et al., Trained immunity: A smart way to enhance innate immune defence. Molecular Immunology, 2015. 
68(1): p. 40-44. https://doi.org/10.1016/j.molimm.2015.06.019 
 
 
 
Publish your research article in AIJR journals- 
• Online Submission and Tracking 
• Peer-Reviewed 
• Rapid decision 
• Immediate Publication after acceptance 
• Articles freely available online 
• Retain full copyright of your article. 
Submit your article at journals.aijr.in  
Publish your books with AIJR publisher- 
• Publish with ISBN and DOI. 
• Publish Thesis/Dissertation as Monograph. 
• Publish Book Monograph. 
• Publish Edited Volume/ Book. 
• Publish Conference Proceedings 
• Retain full copyright of your books. 
Submit your manuscript at books.aijr.org 
